Introducing

The biopharma industry’s first fully integrated data asset is paving the way for breakthroughs in drug development and commercialisation

Billion Dollar Blueprint: The Journey to Blockbuster Status.

What’s the secret formula for creating the next pharmaceutical behemoth? In this eBook discover whether indication expansion drives revenue growth, the pros and cons of in-house vs. outsourced development, and more.

Evaluate World Preview 2024: Pharma's Growth Boost

Last year’s Age of Uncertainty has given way to more predictable realities, including the dominance of obesity and other big diseases, a wider range of modalities and an IRA that’s here to stay. Check out all the data and analysis in the new report.

Licence Drivers: Trends in Pharma Dealmaking

Licensing deals are a critical part of the symbiotic relationship between Big Pharma and biotechs. Big players, many of whom are facing down huge losses through patent expiry, have to balance risk aversion with the need to strengthen pipelines. Meanwhile, biotech and smaller pharma companies must secure investment to get their assets to the next stage.

Obesity: The Next Questions

Before the incretin drug class proved its potential, the notion that obesity could be treated with a pill or injection was almost science fiction. Now, it’s very much fact and the big question is; how large could this market become?

AI and ML in Pharma: Redefining the Forecasting Landscape

Join leading experts from J+D Forecasting as they shed light on the transformative potential of AI and ML in pharmaceutical forecasting, enabling more precise predictions, improved decision-making, and strategic guidance for the industry.

Evaluate radically transforms your confidence in strategic portfolio decisions.

In biopharma, making the right decisions has an incredible impact on patients’ lives. Making those decisions requires a deep understanding of your market; from identifying opportunities and mitigating risk to evaluating assets and pipelines.

Evaluate provides a complete and dynamic view of the pharmaceutical market, with innovative solutions that bring together technology, real world data, and deep expertise to help you make portfolio decisions that drive growth.

HOW WE HELP

Connected data gives you a clearer picture.

Evaluate gives you the understanding and time you need to drive better decisions.

Market Opportunity Sizing

Identify the market that offers the greatest potential for your business so you can confidently prioritise assets and allocate resources.

Commercial Opportunity Assessment

Develop a robust view of potential partners and licensing opportunities to boost your pipeline and amplify your commercial success.

Competitive Landscape Analysis

Build a clear analysis of the evolving landscape – market dynamics, emerging trends and key players – and make strategic moves that strengthen your position.

Company Profiling

Monitor key companies so you can track potential partners and competitors and find opportunities in a constantly changing environment.

Asset Screening

Obtain a clear and unbiased assessment of asset value to drive licensing decisions and ensure you invest in assets with the highest potential for success.

Deal Benchmarking

Bring confidence to your allocation strategy with timely external benchmarking data across the R&D landscape.

We collect,
collaborate and connect.

OUR SOLUTIONS

Insight at Your Fingertips

Access our world-class forecasting, analysis and machine learning-driven insight to help you reduce risk, maximise returns, and make smarter decisions about your portfolio strategy.

MARKET REPORTS

Trends & Analysis

Dive into our market reports covering sector performance and valuation, emerging trends and global forecasts. Stay ahead of the competition with the latest developments that impact your portfolio strategy.

OUR SERVICES

Consulting & Analytics

Tap into our expertise and reach your goals with our collaborative team of specialists, providing technology-enabled consulting, strategic commercial insights, and recommendations across the product lifecycle.

Latest Solutions & Insights

Understand the context. Data-driven insights and analysis for the pharma, biotech and medtech sectors.

October 2, 2024

Ready to learn more? Contact us today to get started.